Alpex Solar Ltd Q1 FY2026 Concall Summary & Transcript Notes

Source transcript PDF: https://www.stockscans.in/document/0eopygfz9rq4wrxxo46gkt84.pdf

# 1. Financial Performance

## A. Key Figures
   *   **Revenue:** **₹76 Cr** Q1 FY25 → **₹380 Cr** Q1 FY26 (QoQ surge) · **₹400 Cr** FY24 → **₹780 Cr** FY25 (+95% YoY)
   *   **EBITDA:** **₹4 Cr** → **₹65 Cr** (QoQ) · **₹38 Cr** → **₹128 Cr** (YoY)
   *   **PAT:** **₹1 Cr** → **₹42 Cr** (QoQ) · **₹29 Cr** → **₹83 Cr** (YoY)
   *   **EBITDA Margin:** **5%** → **17%** (QoQ, +1200 bps)
   * PAT Margin: 1.4% → 11% (QoQ)

## B. Profit Margins
   *   **Margin Expansion Confirmed:** Significant improvement in profitability driven by operational scaling, with EBITDA and PAT margins showing strong upward leverage.
   *   **Margin Volatility Noted:** Operating margins in Q1 and Q4 were around **5%**, below peak levels in prior Q2–Q3, indicating seasonal or mix-related fluctuations.
   *   **Guidance Gap:** Management refrained from confirming sustained operating leverage or future margin trajectory, creating uncertainty on profit sustainability.

## C. Balance Sheet
   *   **Credit Strength Maintained:** CRISIL reaffirmed **BBB (positive outlook)** long-term and **NE3+** short-term ratings, signaling stable credit profile.
   *   **Self-Funded Growth Model:** Majority of CAPEX met through internal accruals, with minimal debt use and selective equity top-up via preferential issuance.
   *   **Controlled Leverage Path:** Potential to raise up to **₹150 Cr** in debt for expansion while preserving near-zero net debt status.

---

# 2. Order Book & Demand

## A. Key Figures
   *   **Order Book:** **₹1,600 Cr** (~5 months) · **Target: ₹3,000 Cr** for next FY
   *   **Major Orders:** **₹45 Cr** (MSEDCL) · **₹210 Cr** (SECI) · **₹65 Cr** (HAREDA) · **₹245 Cr** (CMPCIL) · **₹989 Cr** (3 OEMs)
   * **Realization:** **₹1.7 Cr/MW** expected to remain stable or rise
   *   **DCR vs Non-DCR Mix:** **55% DCR**, **45% non-DCR**
   *   **Module Prices:** **₹24/Wp DCR**, **₹15/Wp non-DCR**

## B. Order Book & Demand Trends
   *   **Robust Order Momentum:** Strong early-year order intake of ₹1,600 Cr reflects leadership in domestic solar demand, with expectations to add **~₹1,000 Cr** in new orders over the next seven months.
   *   **Strategic Mix Advantage:** Overweight DCR exposure (55%) positions the company favorably under tightening domestic manufacturing mandates, with **~98% of India’s future solar panels** expected to be locally made.
   *   **Pricing Resilience:** Near-term price stability or upside expected due to strong demand, ALCM rollout, and **dynamic pricing in new contracts** that reflect market fluctuations.

## C. Market Strategy & Competitive Positioning
   *   **Domestic-Centric Growth:** Majority of revenue from India, driven by government schemes (Surya Ghar, KUSUM) and rising C&I/IPP demand, underpinning a **40–50 GW market opportunity**.
   *   **Selective Global Reach:** US opportunities focused on **cell exports**, leveraging limited non-Chinese supply; module exports constrained by high domestic order visibility and execution priorities.
   *   **Margin Protection:** No near-term margin pressure expected despite input cost risks, supported by favorable production timing and **peer-comparable profitability** on 6 GW Mono PERC lines.
   *   **Key Clientele & Order Security:** Backed by marquee clients including **Tata Power, NTPC, Indian Oil**, though **not all contracts include cell price pass-through**, increasing execution risk on fixed-price orders like SECI’s ₹210 Cr deal.

---

# 3. Manufacturing & Capacity

## A. Key Figures
   * **Module Capacity:** **1.2 GW** operational · **3.6 GW** targeted within two years
   * Cell Capacity: 1.6 GW planned via phased rollout, with 500 MW by year-end

## B. Module Capacity
   *   **Phased Expansion on Track:** Module capacity set to reach **6 GW** through three **2 GW** phases—Greater Noida (Phase-I), Eco-tech (FY25-26), and Kosi, MP (FY26-27)—with next **2 GW** coming online by November.
   *   **Integrated Strategy with Flexibility:** While targeting full vertical integration, company may **partially outsource cell supply** if better revenue opportunities exist, even with **6 GW in-house cell capacity** planned.
   *   **High-End Equipment Sourcing:** Entire module lines sourced from **Korea, Taiwan, and China**, using only new machinery to ensure technological parity with global leaders.

## C. Cell Line Expansion
   *   **Cell Project Execution Accelerating:** **6 GW cell line** in Kosi progressing rapidly using **Mono PERC and Topcon** tech, with first **500 MW** expected by end-FY, supported by Taiwanese, Malaysian, and Chinese EPC teams.
   *   **Commissioning Timeline Signals Market Readiness:** Full **cell line commissioning by August 2026** expected to generate strong market response and underpin future module supply.

## D. Land & Facilities
   *   **Strategic Land Bank Secured:** **21 acres** in MPIDC industrial park allocated in Madhya Pradesh for integrated solar cell and module manufacturing, with expansion announcement pending post-stabilization.
   *   **Multi-Unit Manufacturing Footprint:** Six planned facilities including **Unit-I (Greater Noida, module HQ)**, **Unit-II (Kosi, cell focus)**, and satellite units for ancillaries and future scale, plus trained engineering teams being deployed to **Taiwan and China**.

---

# 4. Vertical Integration

## A. Key Figures
   *   **Aluminum Frame Capacity:** **12,000 MT/year** (6,000 MT Greater Noida + 6,000 MT Kosi)
   *   **EPC Target:** **15 MW FY25** · **95 MW FY26** · **150 MW by FY27**
   *   **IPP Target:** **60 MW by FY26** · **100 MW by FY27**
   *   **Cell Cost Share:** **50–55%** of total module cost

## B. Cell & Frame Production
   *   **Backward Integration Fully Operational:** In-house aluminum frame production at full scale, de-risking supply and supporting module cost control.
   *   **Strategic Cell Sourcing Mix:** Partnerships with Tata Power Solar and Jupiter ensure compliance with DCR norms amid limited domestic supply; **non-DCR cells cost ~₹35**, significantly below **DCR cell price of ₹104**, enabling margin optimization.
   *   **Monetization Option for Excess Capacity:** Potential to sell surplus in-house cell output to third-party module makers if commercially advantageous.

## C. EPC & IPP Growth
   *   **Forward Integration Driving Competitive Edge:** Entry into EPC and IPP segments leverages ALMM restrictions, which bar Chinese panel imports, giving integrated players like Alpex a structural advantage over standalone EPC/IPP firms.
   *   **Integrated Model Enhances Margins & Visibility:** Higher profitability in cell manufacturing versus modules, combined with secured EPC/IPP order pipeline, supports sustainable top-line and bottom-line expansion.
   *   **Corporate Restructuring for Scalability:** New entities—Alpex Green Energy (EPC/IPP) and Alpex GH2 (R&D)—signal strategic evolution into a diversified solar group with clear operational segmentation.

## D. In-House vs Outsourced
   *   **Flexible Cell Strategy Balances Regulation & Economics:** Open-market access allows dynamic allocation—DCR cells for domestic projects, lower-cost alternatives for non-DCR orders—maximizing revenue per order.

---

# 5. Technology & Product

## A. Key Figures
   *   **Industry EBITDA Margin:** **~35%** for integrated cell-module players · **Net Profit Margin:** **~25%** expected within **6–8 months** of full integration

## B. Mono PERC Focus
   *   **Technology Anchoring:** Decision to begin with **Mono PERC cell production** driven by 18 years of legacy expertise, minimizing execution risk versus leapfrogging to newer technologies.
   *   **Tech Differentiation:** PERC and Topcon are viewed as stable, evolutionary pathways, clearly distinct from **HGT**, which remains unproven at scale.

## C. Topcon Transition Plan
   *   **Phased Technology Roadmap:** Initial focus on maximizing **Mono PERC capacity utilization** amid strong order book, with **future transition to Topcon** via retrofitting existing lines as market adoption matures.
   *   **Demand Longevity:** Mono PERC demand expected to remain resilient for **3–4 years**, providing a stable bridge to next-gen technology cycles.

## D. HGT Technology View
   *   **HGT Rejection Rationale:** Technology dismissed due to **high production costs** and lack of discernible performance or cost advantages over current platforms.

---

# 6. Risks & Industry Challenges

## A. Competitive Landscape
   *   **Rising Competition, Structural Barriers:** Increasing entrants in solar manufacturing, including ME participants and firms using second-hand Chinese machinery, but technical complexity of cell production may limit actual execution.
   *   **First-Mover Advantage:** Company leverages **nearly 18 years of manufacturing experience** and early establishment of cell production capacity ahead of peers, providing a strategic edge.
   *   **Domestic Market Shifts:** Growing local competition as exporters like **Vikram Solar** refocus on India, amid a rapidly expanding market that continues to offer space for capable players.

## B. Export & Regulatory Headwinds

---

# 7. Guidance & Outlook

## A. Key Figures
   *   **CAPEX:** **₹600 Cr** (₹240 Cr raised via warrants/preferential, ₹360 Cr pending funding)
   * CAPEX (1.6 GW cell line): ₹642 Cr (all new machinery)
   * CAPEX (1.2 GW module capacity): ₹110 Cr (internal accruals/small loan)

## B. 2x Growth Target
   *   **Guidance Reaffirmed:** Management maintains **2x growth by FY27** as official target, reflecting a conservative, measured expansion strategy despite potential to exceed.
   *   **Growth Trajectory:** Momentum remains strong, with expectations of **robust growth** and incremental order additions in coming quarters.
   *   **Profitability Outlook:** Post-cell ramp-up, **PAT margins targeted near 25%**, with potential for earnings to exceed current guidance if targets are achieved.

## C. Margin Expectations
   *   **Margin Expansion Path:** Alpex Solar expects to **maintain or improve margins** as capacity utilization increases, leveraging scale from new cell and module lines.

## D. CAPEX Timeline
   *   **Project Milestones:** Phase-I of solar cell plant and IPP project expected online by **end of FY26**; **first cell production targeted for end-Feb to early Mar**, with **ALCM certification expected by June**.
   *   **Funding Strategy:** No further equity dilution planned post-current preferential issue; balance CAPEX to be funded via **internal accruals and minimal debt**.
   *   **Expansion On Track:** Full CAPEX deployment expected by **July–August next year**; new capacity expansion ahead of initial March 2026 schedule, with all lines set to commence by **July 2026**.